| AD | Atopic Dermatitis |
| CT | Clinical Trial |
| DAMD | Dupilumab-Associated Mucin Deficiency |
| DAC | Dupilumab-Associated Conjunctivitis |
| EMA | European Medicines Agency |
| EASI | Eczema Area and Severity Index |
| FDA | Food and Drug Administration |
| IL | Interleukin |
| MUC5AC | Mucin 5AC |
| TBUT | Tear Film Break-Up Time |
| Th2 | T-helper 2 cells |
| RCT | Randomized Controlled Trial |